{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:09:42Z","timestamp":1774314582721,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,10]]},"DOI":"10.7759\/cureus.103392","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T07:02:00Z","timestamp":1770793320000},"source":"Crossref","is-referenced-by-count":1,"title":["Spontaneous Regression of a Retinal Mass With Epstein-Barr Virus-Positive and Cytomegalovirus-Positive Panuveitis in Methotrexate-Associated Lymphoproliferative Disorder"],"prefix":"10.7759","author":[{"given":"Ryunosuke","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Koto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Keino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2014.962996","article-title":"Methotrexate: an old new drug in autoimmune disease","volume":"10","author":"Cipriani P","year":"2014","unstructured":"Cipriani P, Ruscitti P, Carubbi F, Liakouli V, Giacomelli R. Methotrexate: an old new drug in autoimmune disease. Expert Rev Clin Immunol. 2014, 10:1519-30. 10.1586\/1744666X.2014.962996","journal-title":"Expert Rev Clin Immunol"},{"key":"ref2","article-title":"Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate","volume":"18","author":"Ellman MH","year":"1991","unstructured":"Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol. 1991, 18:1741-3.","journal-title":"J Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.19007","article-title":"Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders","volume":"59","author":"Tokuhira M","year":"2019","unstructured":"Tokuhira M, Tamaru JI, Kizaki M. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders. J Clin Exp Hematop. 2019, 59:72-92. 10.3960\/jslrt.19007","journal-title":"J Clin Exp Hematop"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13249","article-title":"Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types","volume":"108","author":"Gion Y","year":"2017","unstructured":"Gion Y, Iwaki N, Takata K, et al.. Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types. Cancer Sci. 2017, 108:1271-80. 10.1111\/cas.13249","journal-title":"Cancer Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2019.1668428","article-title":"Primary intraocular methotrexate-related lymphoproliferative disorder in a patient with rheumatoid arthritis undergoing long-term methotrexate therapy","volume":"29","author":"Sone K","year":"2021","unstructured":"Sone K, Usui Y, Fujii K, Goto H. Primary intraocular methotrexate-related lymphoproliferative disorder in a patient with rheumatoid arthritis undergoing long-term methotrexate therapy. Ocul Immunol Inflamm. 2021, 29:456-9. 10.1080\/09273948.2019.1668428","journal-title":"Ocul Immunol Inflamm"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2021.1878233","article-title":"Consensus recommendations for the diagnosis of vitreoretinal lymphoma","volume":"29","author":"Carbonell D","year":"2021","unstructured":"Carbonell D, Mahajan S, Chee SP, et al.. Consensus recommendations for the diagnosis of vitreoretinal lymphoma. Ocul Immunol Inflamm. 2021, 29:507-20. 10.1080\/09273948.2021.1878233","journal-title":"Ocul Immunol Inflamm"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12116","article-title":"Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression","volume":"91","author":"Ichikawa A","year":"2013","unstructured":"Ichikawa A, Arakawa F, Kiyasu J, et al.. Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol. 2013, 91:20-8. 10.1111\/ejh.12116","journal-title":"Eur J Haematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/lgfbtq","article-title":"Involvement of Epstein-Barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis","volume":"40","author":"Kitamura N","year":"2022","unstructured":"Kitamura N, Sugiyama K, Nagasawa Y, Hamaguchi M, Kobayashi H, Takei M. Involvement of Epstein-Barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2022, 40:1330-5. 10.55563\/clinexprheumatol\/lgfbtq","journal-title":"Clin Exp Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-008-0589-8","article-title":"Quantitative PCR for the detection of genomic DNA of Epstein-Barr virus in ocular fluids of patients with uveitis","volume":"52","author":"Yamamoto S","year":"2008","unstructured":"Yamamoto S, Sugita S, Sugamoto Y, Shimizu N, Morio T, Mochizuki M. Quantitative PCR for the detection of genomic DNA of Epstein-Barr virus in ocular fluids of patients with uveitis. Jpn J Ophthalmol. 2008, 52:463-7. 10.1007\/s10384-008-0589-8","journal-title":"Jpn J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-024-00434-w","article-title":"Cytomegalovirus chronic retinal necrosis with ganciclovir resistance: a case report","volume":"14","author":"Xia J","year":"2024","unstructured":"Xia J, Kantipudi S, Striebich CC, Henao-Martinez AF, Manoharan N, Palestine AG, Reddy AK. Cytomegalovirus chronic retinal necrosis with ganciclovir resistance: a case report. J Ophthalmic Inflamm Infect. 2024, 14:50. 10.1186\/s12348-024-00434-w","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2025.102453","article-title":"Ebstein-Bar Virus (EBV)-Positive diffuse large B-cell vitreoretinal lymphoma: two cases without overt immunocompromise and review of the literature","volume":"40","author":"Zafar S","year":"2025","unstructured":"Zafar S, August AH, Milman T, Deaner JD. Ebstein-Bar Virus (EBV)-Positive diffuse large B-cell vitreoretinal lymphoma: two cases without overt immunocompromise and review of the literature. Am J Ophthalmol Case Rep. 2025, 40:102453. 10.1016\/j.ajoc.2025.102453","journal-title":"Am J Ophthalmol Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/463495-spontaneous-regression-of-a-retinal-mass-with-epstein-barr-virus-positive-and-cytomegalovirus-positive-panuveitis-in-methotrexate-associated-lymphoproliferative-disorder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T07:02:00Z","timestamp":1770793320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/463495-spontaneous-regression-of-a-retinal-mass-with-epstein-barr-virus-positive-and-cytomegalovirus-positive-panuveitis-in-methotrexate-associated-lymphoproliferative-disorder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.103392","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}